CRP and rheumatoid arthritis: Despite PSM, we could not adjust for key unmeasured confounders such as RA disease activity (e.g., DAS28), inflammatory markers (e.g., CRP and ESR), antibody status, functional status, corticosteroid use, or lifestyle factors, all of which heavily influence both drug choice and outcomes.